Results 231 to 240 of about 234,679 (371)

Vasoplegia after pediatric cardiac transplantation in patients supported with a continuous flow ventricular assist device [PDF]

, 2019
Loren D. Sacks, Seth A. Hollander, Yulin Zhang, Kathleen R. Ryan, Mackenzie A. Ford, Katsuhide Maeda, Jenna Murray, Christopher S. Almond, David M. Kwiatkowski   +8 more
openalex   +1 more source

Commentary: Left ventricular assist device therapy: The time is now [PDF]

, 2020
Arman Kilic
openalex   +1 more source

Use of glucagon-like peptide-1 receptor agonists in patients with left ventricular assist devices. [PDF]

ESC Heart Fail
Ibrahim R, Nhat H, Abdelnabi M, Forst B, Allam M, Mee XC, Lim GK, Bcharah G, Barry T, Farina J, Ayoub C, Arsanjani R, Lee K.   +12 more
europepmc   +1 more source

Improved Systemic Saturation after Ventricular Assist Device Implantation in a Patient with Decompensated Dextro-Transposition of the Great Arteries after the Fontan Procedure [PDF]

, 2015
Ali Abdul Jabbar, Wayne Franklin, Leo Simpson, Andrew B. Civitello, Reynolds M. Delgado, O.H. Frazier   +5 more
openalex   +1 more source

Myocardial inflammation is associated with impaired mitochondrial oxidative capacity in ischaemic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1246-1255, April 2025.
Abstract Aims Myocardial inflammation and impaired mitochondrial oxidative capacity are hallmarks of heart failure (HF) pathophysiology. The extent of myocardial inflammation in patients suffering from ischaemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM) and its association with mitochondrial energy metabolism are unknown.
Julius Borger, Elric Zweck, Constanze Moos, Patrick Horn, Fabian Voß, Heinz‐Peter Schultheiss, Jacob Eifer Møller, Udo Boeken, Hug Aubin, Artur Lichtenberg, Malte Kelm, Michael Roden, Amin Polzin, Ralf Westenfeld, Julia Szendroedi, Daniel Scheiber   +15 more
wiley   +1 more source

A Thematic Qualitative Synthesis on the Lived Experiences of Patients With Left Ventricular Assist Devices: A Journey From Vulnerability to Resilience. [PDF]

Nurs Crit Care
Koutsavli D, Kalogianni A, Misouridou E, Souvatzi EB, Timmins F, Parissopoulos S.   +5 more
europepmc   +1 more source

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

ESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh, Katharina Koepsel, Julia W. Erath, Thomas Kuntz, Norbert Klein, Boldizsar Kovacs, Firat Duru, Ardan M. Saguner, Christian Blockhaus, Dong‐In Shin, Fabienne Kreimer, Michael Gotzmann, Hendrik Lapp, Thomas Beiert, Assem Aweimer, Andreas Mügge, Christel Weiß, Ibrahim El‐Battrawy, Ibrahim Akin   +18 more
wiley   +1 more source

Ventricular assist device

, 2019
Maedeh Dorri, Craig Hacking, Henry Knipe
openaire   +1 more source

Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial [PDF]

, 2018
et al,, Itoh, Akinobu
core   +1 more source

Multicenter Evaluation of Octreotide as Secondary Prophylaxis in Patients With Left Ventricular Assist Devices and Gastrointestinal Bleeding

Circulation: Heart Failure, 2017
K. Shah, S. Gunda, S. Emani, M. Kanwar, N. Uriel, P. Colombo, P. Uber, M. L. Sears, J. Chuang, D. Farrar, D. Brophy, G. Smallfield   +11 more
semanticscholar   +1 more source